Phase 1 Cholesterolemia Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Recruiting
Phase 1
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
HypercholesterolemiaHypertriglyceridemiaRefractory Hyperlipidemia
Verve Therapeutics, Inc.36 enrolled10 locationsNCT06451770
Recruiting
Phase 1
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Premature Coronary Heart DiseaseHeterozygous Familial Hypercholesterolemia
Verve Therapeutics, Inc.85 enrolled22 locationsNCT06164730
Recruiting
Phase 1
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
HypercholesterolaemiaMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG90 enrolled18 locationsNCT07491172
Terminated
Phase 1
A Study to Evaluate SGB-3403 in Healthy Volunteers
Hypercholesterolemia
Sanegene Bio Australia Pty Ltd37 enrolled1 locationACTRN12623000439640
Not Yet Recruiting
Phase 1
Supplementation of Oil Palm Phenolics in Healthy Subjects
HypercholesterolemiaHyperlipidaemia
Economic Planning Unit. Prime Minister’s Department. Malaysia100 enrolled1 locationACTRN12619001786189
Completed
Phase 1
A human trial to evaluate the performance and safety of a new formulation containing a cholesterol-lowering drug to healthy male volunteers.
Hypercholesterolemia
Reform Pharm Pty Ltd14 enrolled1 locationACTRN12618001929291
Completed
Phase 1
Palm Fruit Juice Supplementation in Healthy Volunteers
Pre-diabetesHypercholesterolemia
Malaysian Ministry of Agriculture & Agrobased industry25 enrolled1 locationACTRN12611001122943